期刊文献+

呼吸道合胞病毒G-LTB融合蛋白的表达

Expression of recombinant fusion protein of RSV G-LTB in E.coli
原文传递
导出
摘要 通过Linker连接呼吸道合胞病毒(RSV)G蛋白的部分抗原决定簇基因与大肠杆菌热不稳定肠毒素B亚单位基因(LTB)融合,构成融合基因,构建原核表达重组质粒并进行表达,并初步研究其免疫反应.构建得到的重组表达质粒,转化大肠杆菌后融合蛋白在大肠杆菌中得到了表达,用SDS-PAGE和Western-blotting对表达产物进行鉴定,融合蛋白的分子量约为25 ku.该蛋白能够被LT特异性抗体识别.成功表达呼吸道合胞病毒部分G蛋白与LTB的融合蛋白,并且该蛋白有一定的免疫原性. To investigate the immunogenicity of recombinant mucous membrance vaccine of respiratory syncytial virus, a fusion protein gene was constructed by linking G: 130 ~ 230 and LTB gene with a linker and expressed in E. coli. The recombinant plasmid was transferred into E. coli and target protein was expressed in E. coli. The fusion protein was determined by SDS - PAGE and western - blotting. The molecular mass of fusion protein was estimate to be 25 ku. The fusion protein can be specificly recognized by LT antibody.The fusion protein showed certain immunity.
出处 《云南大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第S3期355-359,共5页 Journal of Yunnan University(Natural Sciences Edition)
基金 国家自然科学基金资助项目(30570929) 昆明理工大学科学研究基金资助项目(2005-8)
关键词 呼吸道合胞病毒 融合蛋白 免疫原性 粘膜疫苗 respiratory syncytial virus (RSV) fusion protein LTB- G immunogenicity mucous membrane vaccine
  • 相关文献

参考文献11

  • 1刘陶陶,李淑琴,张兆山,郑继平,刘秀丽,罗刚,黄翠芬.肠毒素大肠杆菌CS3定居因子抗原和融合肠毒素基因在减毒痢疾杆菌中的共表达[J].生物化学与生物物理学报,2003,35(1):49-54. 被引量:5
  • 2O’’ DOWD A M,BOTTING C H,PRECIOUS B,et al.Novel modifications to the C-terminus of LTB that facilitate site-directed chemical coupling of antigens and the development of LTB as a carrier for mucosal vaccines[ J][].Vaccine.1999
  • 3SULLENDER W M,BRITT W J.Antigenic and immunogenic analysis of group A and group B respiratory syncytial virus G proteins expressed from recombinant baculoviruses[].Journal of General Virology.1996
  • 4GODEFROY S,GOESTCH L,PLOTNICKY-GILQUIN H,et al.Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against respiratory syncytial virus (RSV)[].Vaccine.2003
  • 5ROCCO S,MEDAGLINI D,RUSH C M,et al.Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii[].Infection and Immunity.2000
  • 6Piedra PA.Clinicalexperience with respiratory syncy-tial virus vaccines[].Pediatric Infectious Disease.2003
  • 7Brandenburg AH,Neijens HJ,Osterhaus AD.Pathogenesis of RSV lower respiratory tract infection:implications for vaccine development[].Vaccine.2001
  • 8Sylvia A,Lolke H,Arron R,et al.MutantEscherichia coliheat-labile toxin B subunit that separates toxoid-mediated sig-naling and immunomodulatory action from trafficking and de-livery functions[].Infection and Immunity.2003
  • 9L. Goetsch H. Plotnicky-Gilquin J. P. Aubry,P. De-Lys,J. F. Haeuw,J. Y. Bonnefoy,N. T. Nguyen,N. Corvaa and D. Velin.BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in mice[].Vaccine.2001
  • 10Hacking D,Hull J.Respiratory syncytial virus-viral biology and the host response[].Journal of Infection.2002

二级参考文献4

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部